Phase I study of NBI-98854 in male volunteers.
Phase of Trial: Phase I
Latest Information Update: 24 May 2017
At a glance
- Drugs Valbenazine (Primary)
- Indications Drug-induced dyskinesia
- Focus Pharmacokinetics
- Sponsors Neurocrine Biosciences
- 18 Oct 2010 Status changed from recruiting to completed, according to a Neurocrine Biosciences media release.
- 13 Apr 2010 Status changed from planning to recruiting, according to a Neurocrine Biosciences media release.
- 24 Dec 2009 New trial record